Chapter 1: Executive summary

1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary

Chapter 2: Cancer screening market in the U.S.A. - market overview

2.1. The U.S.A. market overview – market trends, market attractiveness analysis, geography-wise market revenue (USD)
2.2. The U.S.A. – market drivers and challenges
2.3. Value chain analysis – cancer screening market in the USA
2.4. Porter’s five forces analysis

Chapter 3. Cancer screening market in the U.S.A. - by end users

3.1. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. Independent physicians and clinics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 4. Cancer screening market in the U.S.A. - by screening type

4.1. Laboratory testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.2. Genetic testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3. Imaging testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4. Biopsy testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.5. Endoscopy testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 5. Cancer screening market in the U.S.A. - by application

5.1. Lung cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.2. Breast cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3. Melanoma cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4. Kidney cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.5. Colorectal cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 6: Competitive landscape

6.1. Roche Diagnostics (*)
6.1. a. Company snapshot
6.1. b. Product offerings
6.1. c. Growth strategies
6.1. d. Initiatives
6.1. e. Geographical presence
6.1. f. Key numbers
6.2. Abbott laboratories
6.3. GE Healthcare
6.4. Qiagen
6.5. Thermo Fisher Scientific
6.6. Siemens Healthineers
(*) all the information are similar for the mentioned companies

Chapter 7: Conclusion

Chapter 8: Appendix

8.1. List of tables
8.2. Assumptions
8.3. Research and methodology